Maryland Subject | Opioids | Senate

Filter View [Reset All]
Syndicate content
StanceStateBillStatusSummary/TitleLast Actionsort icon
MDSB408Enroll
75%
Requiring the Maryland Department of Health to report, on or before December 1, 2024, December 1, 2025, and December 1, 2026, to the Senate Finance Committee and the House Health and Government Operations Committee on current opioid overdose reversal...
[Detail][Text][Discuss]
2024-04-08
Returned Passed
MDSB1099Enroll
75%
Requiring the State Emergency Medical Services Board, in collaboration with the Maryland Department of Health, to develop and implement an initiative under the Public Access Automated External Defibrillator Program to require that naloxone be co-loca...
[Detail][Text][Discuss]
2024-04-08
Passed Enrolled
MDSB1071Enroll
75%
Requiring hospitals to establish and maintain certain protocols and capacity related to the treatment of patients who are being treated for an opioid-related overdose or opioid-related emergency medical condition; requiring hospitals to make a referr...
[Detail][Text][Discuss]
2024-04-05
Passed Enrolled
MDSB751Enroll
75%
Requiring the Secretary of Health to present decisions for the allocations of money from the Opioid Restitution Fund to the Opioid Restitution Fund Advisory Council; requiring the Maryland Department of Health to post on the Department's website cert...
[Detail][Text][Discuss]
2024-04-03
Returned Passed
MDSB497Intro
25%
Requiring the Maryland Medical Assistance Program and certain insurers, nonprofit health service plans, and health maintenance organizations to cover nonprescription naloxone hydrochloride and any other drug or product that is approved by the federal...
[Detail][Text][Discuss]
2024-03-04
Withdrawn by Sponsor
MDSB1075Intro
25%
Prohibiting an individual from distributing heroin or fentanyl or chemical analogues of heroin or fentanyl, the use of which results in the death or serious bodily injury of another.
[Detail][Text][Discuss]
2024-02-07
To Senate Judicial Proceedings Committee
MDSB801Intro
25%
Repealing the requirement that each local correctional facility make available at least one formulation of each FDA-approved full opioid agonist, partial opioid agonist, and long-acting opioid antagonist used for the treatment of opioid use disorders...
[Detail][Text][Discuss]
2024-02-06
To Senate Budget and Taxation Committee
MDSB282Intro
25%
Altering a certain requirement that the Governor's Office of Crime Prevention, Youth, and Victim Services annually report to the General Assembly about opioid use disorder among incarcerated individuals in local correctional facilities by repealing c...
[Detail][Text][Discuss]
2024-01-15
To Senate Judicial Proceedings Committee
Syndicate content
feedback